Last reviewed · How we verify
NCT01706588: DP4
Preliminary Evaluation of the Efficacy and Local Tolerability of Injectable Diclofenac at 5, 12.5, 25 and 50 mg/mL, Administered Locally Prior to Surgery for the Prevention of Post-operative Pain After Third Molar Surgery
Phase 2 trial testing Diclofenac sodium in Pain in 75 participants. Completed in 1 May 2013.
1 May 2013
Quick facts
| Lead sponsor | IBSA Institut Biochimique SA |
|---|---|
| Phase | Phase 2 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 75 |
| Start date | 1 January 2013 |
| Primary completion | 1 May 2013 |
| Estimated completion | 1 May 2013 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Diclofenac sodium (Diclofenac Sodium) — full drug profile →
Conditions studied
- Pain — all drugs for Pain →
Sponsor
IBSA Institut Biochimique SA — full company profile →
Who can join
Adults 18 to 65, any sex, with Pain. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Area Under the Curve (AUC) of the Pain Scores.
Time frame: Pain scores will be measured over the time from end of surgery (time 0) to the 6 hour post-surgery
Pain will be scored by the patient at the end of surgery (time 0) and at 15-minute intervals after surgery for a total of 6 hours on a 0-100 mm VAS (from 0 = no pain to 100 = worst pain imaginable).
Sponsor's own description
This is a prospective, randomised, double-blind, placebo-controlled, parallel group study in approximately 75 patients undergoing surgical removal of an impacted lower third molar.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Submucosal Diclofenac for Acute Postoperative Pain in Third Molar Surgery: A Randomized, Controlled Clinical Trial.
Gorecki P, Rainsford KD, Taneja P, Bulsara Y, et al · · 2018 · cited 12× · PMID 29202646 · DOI 10.1177/0022034517744207
Verify or expand the search:
- PubMed search for NCT01706588
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Diclofenac sodium
Trials testing the same drug.
- NCT07565012 — Comparative Evaluation of Diclofenac Sodium and Ibuprofen for Post-Endodontic Pain Management · Phase 4 · completed
- NCT07237620 — The Effect of Different Intracanal Medicaments on Periapical Lesion Healing · NA · recruiting
- NCT06090500 — Effect of Submucosal Cryotherapy on Postoperative Endodontic Pain · NA · completed
- NCT03221946 — A Comparative Evaluation of Diclofenac Sodium Transdermal Patch, Oral Diclofenac Sodium With Intramuscular Injections of · Phase 4 · completed
- NCT02201238 — Pharmacokinetics Study Comparing Topical Diclofenac/Menthol Gels With Voltaren Gel and Oral Diclofenac Sodium · Phase 1 · completed
Other recruiting trials for Pain
Currently open trials in the same condition.
- NCT07533409 — Tactile and Pain Sensory Thresholds and Hand Grip Strength · recruiting
- NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07487610 — Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older · recruiting
- NCT07454993 — The Effect of Music During Colonoscopy · NA · recruiting
Other IBSA Institut Biochimique SA trials
Trials by the same sponsor.
- NCT06659692 — Pharmacokinetics of FSH and hCG Following Multiple Dose of Gonadotropins-IBSA. · Phase 1 · completed
- NCT06781957 — Pharmacokinetics of FSH and hCG After a Single Subcutaneous Injection of Gonadotropins-IBSA · Phase 1 · completed
- NCT05490680 — A New Sildenafil Oral Film in Patients With Erectile Dysfunction · Phase 3 · completed
- NCT04549116 — Subcutaneous Progesterone in Frozen- Thawed Single Euploid Blastocyst Transfer. · Phase 3 · active not recruiting
- NCT05228184 — Use of Tirosint®-SOL or Tablet Formulations of Levothyroxine in Pediatric Patients With Congenital Hypothyroidism (CH) · Phase 4 · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01706588 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by IBSA Institut Biochimique SA
- Last refreshed: 28 August 2014
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01706588.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing